#526: Eating Rate, Food Texture & Satiation – Marlou Lasschuijt, PhD
Listen now
Description
Food science and behavior are intimately connected. One critical but often overlooked facet of this connection is food texture and its substantial impact on eating behavior and energy intake. Food texture encompasses characteristics such as hardness and structure. It categorizes food into liquids, semi-solids, and solids, each with a wide range of textures—from dry and crispy to elastic and more substantial. This classification deeply affects how we consume food. The time it takes to chew and swallow a food item can vary greatly based on its texture. Different textures can also influence the speed at which satiety signals are triggered. Eating rate is a highly individual trait, stable over time, and consistent across different contexts. Some people are naturally slower eaters, while others consume food quickly. This variance can have significant implications for energy intake and body weight. In this episode, Dr. Marlou Lasschuijt, an assistant professor in the Sensory Science and Eating Behaviour group at Wageningen University, discusses the above topics and their implications. Links: Subscribe to Sigma Nutrition Premium (for study notes and transcripts) Go to episode page The Restructure Project Receive our free weekly email: the Sigma Synopsis Timestamps: 00:14 Introduction 00:47 Dr. Lasschuijt’s Research Focus 04:23 Understanding Food Texture and Eating Behavior 06:37 Impact of Food Texture on Satiation and Eating Rate 16:55 Applications and Innovations in Food Science 18:31 Unanswered Questions 25:34 Practical Recommendations  27:00 Current and Upcoming Research Projects
More Episodes
Hypertension, commonly known as high blood pressure, is a silent yet prevalent health issue that affects millions of people worldwide. Often going unnoticed until significant damage has been done, hypertension can lead to severe cardiovascular complications if not properly managed. ...
Published 06/25/24
Published 06/25/24
Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-documented, with...
Published 06/11/24